Cargando...
Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibitors in Cancer Treatment
Recently, the development of poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitors has brought a major breakthrough in the treatment of germline breast cancer susceptibility gene (BRCA)-mutant cancers.(1-4) These agents target a DNA repair pathway via a novel mechanism of action. A b...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3600582/ https://ncbi.nlm.nih.gov/pubmed/22520984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2012.02.012 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|